Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06191744
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-12-20
Brief Title:
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide R2 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Sponsor:
Genmab
Organization:
Genmab
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Follicular Lymphoma FL |
Keywords:
| Name | View |
|---|---|
| EPCOREFL-2 | View |
| Follicular Lymphoma FL | View |
| Non-Hodgkins lymphoma NHL | View |
| Lymphoma | View |
| Cancer | View |
| Epcoritamab | View |
| Rituximab | View |
| Lenalidomide | View |
| Chemoimmunotherapy CIT | View |
| Obinutuzumab | View |
| Cyclophosphamide | View |
| Doxorubicin Hydrochloride | View |
| Vincristine Sulfate | View |
| Prednisone | View |
| Bendamustine Benda | View |
| R-CHOP | View |
| G-CHOP | View |
| R-Benda | View |
| G-Benda | View |